CSBR beat EPS expectations by 106.13%
Jul 18, 2024, 8:31 PM
0.00%
What does CSBR do
Champions Oncology, Inc., based in Baltimore, Maryland, develops and sells personalized oncology drug development technologies, employing 230 people and operating a research center in both regulatory and non-regulatory environments. The company offers TumorGraft Technology Platform services to biopharma firms and runs a software-as-a-service business through its Lumin Bioinformatics platform, which integrates data from research and clinical studies for drug discovery and development.
Champions Oncology Inc (CSBR) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Champions Oncology Inc's actual EPS was $0.01, beating the estimate of -$0.16 per share, resulting in a 106.13% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.